Splenomegaly: Difference between revisions

Jump to navigation Jump to search
Line 34: Line 34:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fatigue
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
Line 43: Line 43:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |PS
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
Line 49: Line 48:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
Line 57: Line 57:
! colspan="2" align="center" style="background:#DCDCDC;" |[[Cirrhosis]]
! colspan="2" align="center" style="background:#DCDCDC;" |[[Cirrhosis]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |Any
* Infection
* Alcohol
* Autoimmune
| align="center" style="background:#F5F5F5;" |Any, more in elderly
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Hepatitis]]
* [[Hepatitis]]
* [[Alcoholism|Alcohol use]]
* [[Alcoholism|Alcohol use]]
| align="center" style="background:#F5F5F5;" | -
* [[Non-alcoholic fatty liver disease|NAFLD]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |↑↓
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Spider angiomata
* Palmar erythema
* Weakness
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |Dark urine
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Pancytopenia
* Regenerating nodules of hepatocytes
* Fibrosis
* Deposition of connective tissue between these nodules
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Small and nodular liver on ultrasound
* Fibrosis on liver scan
| align="center" style="background:#F5F5F5;" |Liver biopsy
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Hepatic encephalopathy
| align="center" style="background:#F5F5F5;" |
* Gynecomastia
| align="center" style="background:#F5F5F5;" |
* Hypogonadism
| align="center" style="background:#F5F5F5;" |
* Esophageal varices
| align="center" style="background:#F5F5F5;" |
* Caput medusa
| align="center" style="background:#F5F5F5;" |
* Dupuytren's contracture
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |[[Congestive heart failure|Heart failure]]
! colspan="2" align="center" style="background:#DCDCDC;" |[[Congestive heart failure|Heart failure]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Coronary artery disease
* HTN
| align="center" style="background:#F5F5F5;" |Elderly
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Smoking
* Sedentary lifestyle
* Obstructive sleep apnea
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |↑↓
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Dyspnea
* Weakness
* Chest pain
* Heart murmur
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |↓
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |↑
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Normal or low ejection fraction on echocardiography
* Cardiomegaly on chest xray
| align="center" style="background:#F5F5F5;" |Echocardiography
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Pulmonary edema
| align="center" style="background:#F5F5F5;" |
* Hyponatremia
| align="center" style="background:#F5F5F5;" |
* Elevated BNP
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |[[Thrombosis]] of [[portal]], [[Liver|hepatic]], or [[Splenic vein|splenic veins]]
! colspan="2" align="center" style="background:#DCDCDC;" |[[Thrombosis]] of [[portal]], [[Liver|hepatic]], or [[Splenic vein|splenic veins]]
Line 373: Line 406:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PS
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
Line 379: Line 411:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
Line 838: Line 871:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PS
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
Line 844: Line 876:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
Line 1,111: Line 1,144:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PS
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Iron
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
Line 1,117: Line 1,149:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard

Revision as of 18:33, 27 September 2018

WikiDoc Resources for Splenomegaly

Articles

Most recent articles on Splenomegaly

Most cited articles on Splenomegaly

Review articles on Splenomegaly

Articles on Splenomegaly in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Splenomegaly

Images of Splenomegaly

Photos of Splenomegaly

Podcasts & MP3s on Splenomegaly

Videos on Splenomegaly

Evidence Based Medicine

Cochrane Collaboration on Splenomegaly

Bandolier on Splenomegaly

TRIP on Splenomegaly

Clinical Trials

Ongoing Trials on Splenomegaly at Clinical Trials.gov

Trial results on Splenomegaly

Clinical Trials on Splenomegaly at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Splenomegaly

NICE Guidance on Splenomegaly

NHS PRODIGY Guidance

FDA on Splenomegaly

CDC on Splenomegaly

Books

Books on Splenomegaly

News

Splenomegaly in the news

Be alerted to news on Splenomegaly

News trends on Splenomegaly

Commentary

Blogs on Splenomegaly

Definitions

Definitions of Splenomegaly

Patient Resources / Community

Patient resources on Splenomegaly

Discussion groups on Splenomegaly

Patient Handouts on Splenomegaly

Directions to Hospitals Treating Splenomegaly

Risk calculators and risk factors for Splenomegaly

Healthcare Provider Resources

Symptoms of Splenomegaly

Causes & Risk Factors for Splenomegaly

Diagnostic studies for Splenomegaly

Treatment of Splenomegaly

Continuing Medical Education (CME)

CME Programs on Splenomegaly

International

Splenomegaly en Espanol

Splenomegaly en Francais

Business

Splenomegaly in the Marketplace

Patents on Splenomegaly

Experimental / Informatics

List of terms related to Splenomegaly

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Gichoya Judy Wawira [2], Moi University School of Medicine

Synonyms and keywords: Spleen enlargement; enlarged spleen; spleen swelling

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Splenomegaly from Other Diseases

Category Disease Etiology Clinical manifestations Para−clinical findings Gold standard Associated findings
Demography History Symptoms Signs Lab Findings Imaging
Fever Fatigue Weight Abdominal pain Bleeding BP JVP Jaundice Ascites Other CBC Iron LFT PT/PTT BUN/Cr UA Histopathology
WBC Hb Plt
Congestive Cirrhosis
  • Infection
  • Alcohol
  • Autoimmune
Any, more in elderly + ↑↓ + + Nl + +
  • Spider angiomata
  • Palmar erythema
  • Weakness
Nl Dark urine
  • Pancytopenia
  • Regenerating nodules of hepatocytes
  • Fibrosis
  • Deposition of connective tissue between these nodules
  • Small and nodular liver on ultrasound
  • Fibrosis on liver scan
Liver biopsy
  • Hepatic encephalopathy
  • Gynecomastia
  • Hypogonadism
  • Esophageal varices
  • Caput medusa
  • Dupuytren's contracture
Heart failure
  • Coronary artery disease
  • HTN
Elderly
  • Smoking
  • Sedentary lifestyle
  • Obstructive sleep apnea
+ ↑↓ ± +
  • Dyspnea
  • Weakness
  • Chest pain
  • Heart murmur
Nl Nl NA
  • Normal or low ejection fraction on echocardiography
  • Cardiomegaly on chest xray
Echocardiography
  • Pulmonary edema
  • Hyponatremia
  • Elevated BNP
Thrombosis of portal, hepatic, or splenic veins
Malignancy Lymphoma
Leukemia
Polycythemia Vera
Multiple myeloma
Essential thrombocythemia
Primary myelofibrosis
Primary splenic tumors
Metastatic solid tumors
Category Disease Etiology Demography History Fever Fatigue Weight loss Abdominal pain Bleeding BP JVP Jaundice Ascites Other WBC Hb Plt Iron LFT PT/PTT BUN/Cr UA Histopathology Imaging Gold standard Associated findings
Infection Viral Hepatitis
Infectious mononucleosis
Cytomegalovirus
Bacterial Salmonella
Brucella
Tuberculosis
Parasitic Malaria
Schistosomiasis
Toxoplasmosis
Kala-azar Visceral leishmaniasis
Infective endocarditis
Fungal
Inflammation Sarcoidosis
Serum sickness
Systemic lupus erythematosus
Felty syndrome
Category Disease Etiology Demography History Fever Fatigue Weight loss Abdominal pain Bleeding BP JVP Jaundice Ascites Other WBC Hb Plt Iron LFT PT/PTT BUN/Cr UA Histopathology Imaging Gold standard Associated findings
Infiltrative Gaucher disease
Niemann-Pick disease
Amyloidosis
Langerhans cell histiocytosis
Hemophagocytic lymphohistiocytosis
Rosai-Dorfman disease
Hematologic (hypersplenic) states Hemolytic anemia
Sickle cell disease
Granulocyte colony-stimulating factor
Category Disease Etiology Demography History Fever Fatigue Weight loss Abdominal pain Bleeding BP JVP Jaundice Ascites Other WBC Hb Plt Iron LFT PT/PTT BUN/Cr UA Histopathology Imaging Gold standard Associated findings

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Related Chapters

References